ARL14 as a Prognostic Biomarker in Non-Small Cell Lung Cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–385. doi:10.3322/caac.21565
   PubMed Web of Science ®Google Scholar
• Relli V, Trerotola M, Guerra E, Alberti S. Abandoning the notion of non-small cell lung cancer. Trends Mol Med. 2019;25(7):585–594. doi:10.1016/j.molmed.2019.04.012
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Wood DE, Aggarwal C, et al. NCCN guidelines insights: non-small cell lung cancer, version 1.2020. J Natl Compr Canc Netw. 2019;17(12):1464–1472. doi:10.6004/jnccn.2019.0059
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhou S, Du Y, et al. Efficacy and safety of programmed death 1 inhibitors in patients with advanced non-small cell lung cancer: a meta-analysis. Cancer Manag Res. 2019;11:4619–4630. doi:10.2147/CMAR.S193394
   PubMed Web of Science ®Google Scholar
• Zhang B, Liu Y, Zhou S, Jiang H, Zhu K, Wang R. Predictive effect of PD-L1 expression for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatment for non-small cell lung cancer: a meta-analysis. Int Immunopharmacol. 2020;80:106214. doi:10.1016/j.intimp.2020.106214
   PubMed Web of Science ®Google Scholar
• Liu Y, Li HM, Wang R. Effectiveness and safety of adding bevacizumab to platinum-based chemotherapy as first-line treatment for advanced non-small-cell lung cancer: a meta-analysis. Front Med. 2021;8:616380. doi:10.3389/fmed.2021.616380
   Web of Science ®Google Scholar
• Paul P, van den Hoorn T, Jongsma ML, et al. A genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation. Cell. 2011;145(2):268–283. doi:10.1016/j.cell.2011.03.023
   PubMed Web of Science ®Google Scholar
• Ota T, Suzuki Y, Nishikawa T, et al. Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004;36(1):40–45. doi:10.1038/ng1285
   PubMed Web of Science ®Google Scholar
• Donaldson JG, Jackson CL. ARF family G proteins and their regulators: roles in membrane transport, development and disease. Nat Rev Mol Cell Biol. 2011;12(6):362–375. doi:10.1038/nrm3117
   PubMed Web of Science ®Google Scholar
• Tanna CE, Goss LB, Ludwig CG, Chen PW. Arf GAPs as regulators of the actin cytoskeleton-an update. Int J Mol Sci. 2019;20:2. doi:10.3390/ijms20020442
   Web of Science ®Google Scholar
• Gillingham AK, Munro S. The small G proteins of the Arf family and their regulators. Annu Rev Cell Dev Biol. 2007;23:579–611. doi:10.1146/annurev.cellbio.23.090506.123209
   PubMed Web of Science ®Google Scholar
• Colicelli J. Human RAS superfamily proteins and related GTPases. Sci STKE. 2004;2004(250):Re13. doi:10.1126/stke.2502004re13
   PubMedGoogle Scholar
• Gaudet P, Livstone MS, Lewis SE, Thomas PD. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Brief Bioinform. 2011;12(5):449–462. doi:10.1093/bib/bbr042
   PubMed Web of Science ®Google Scholar
• Wang L, Shi J, Huang Y, et al. A six-gene prognostic model predicts overall survival in bladder cancer patients. Cancer Cell Int. 2019;19:229. doi:10.1186/s12935-019-0950-7
   PubMed Web of Science ®Google Scholar
• Liu J, Liu S, Wu M, et al. ARF3 inhibits proliferation and promotes apoptosis in gastric cancer by regulating AKT and ERK pathway. Acta biochimica Polonica. 2021;68(2):223–229.
   PubMed Web of Science ®Google Scholar
• Liang C, Qin Y, Zhang B, et al. ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancer. Cancer Lett. 2017;388:303–311. doi:10.1016/j.canlet.2016.12.014
   PubMed Web of Science ®Google Scholar
• Rami-Porta R, Bolejack V, Crowley J, et al. The IASLC lung cancer staging project: proposals for the Revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10(7):990–1003. doi:10.1097/JTO.0000000000000559
   PubMed Web of Science ®Google Scholar
• Wang R, Zhou S, Wu P, et al. Identifying involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in treating pulmonary hypertension with melatonin. Mol Ther Nucleic Acids. 2018;13:44–54. doi:10.1016/j.omtn.2018.08.015
   PubMedGoogle Scholar
• Zhou S, Jiang H, Li M, et al. Circular RNA hsa_circ_0016070 is associated with pulmonary arterial hypertension by promoting PASMC proliferation. Mol Ther Nucleic Acids. 2019;18:275–284. doi:10.1016/j.omtn.2019.08.026
   PubMedGoogle Scholar
• Bai Y, Liu X, Qi X, et al. PDIA6 modulates apoptosis and autophagy of non-small cell lung cancer cells via the MAP4K1/JNK signaling pathway. EBioMedicine. 2019;42:311–325. doi:10.1016/j.ebiom.2019.03.045
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Ito K, Murphy D. Application of ggplot2 to pharmacometric graphics. CPT: Pharmacomet Syst Pharmacol. 2013;2(10):e79.
   PubMedGoogle Scholar
• Yang F, Li T, Peng Z, Liu Y, Guo Y. The amphipathic helices of Arfrp1 and Arl14 are sufficient to determine subcellular localizations. J Biol Chem. 2020;295(49):16643–16654. doi:10.1074/jbc.RA120.014999
   PubMed Web of Science ®Google Scholar
• Ninomiya H, Kato M, Sanada M, et al. Allelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes. BMC Cancer. 2013;13:8. doi:10.1186/1471-2407-13-8
   PubMed Web of Science ®Google Scholar
• Du M, Thompson J, Fisher H, Zhang P, Huang CC, Wang L. Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance. Lung Cancer. 2018;120:113–121. doi:10.1016/j.lungcan.2018.04.008
   PubMed Web of Science ®Google Scholar
• Litviakov NV, Cherdyntseva NV, Tsyganov MM, et al. Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy. Oncotarget. 2016;7(7):7829–7841. doi:10.18632/oncotarget.6953
   PubMedGoogle Scholar
• Barrios-Rodiles M, Brown KR, Ozdamar B, et al. High-throughput mapping of a dynamic signaling network in mammalian cells. Science. 2005;307(5715):1621–1625. doi:10.1126/science.1105776
   PubMed Web of Science ®Google Scholar
• Kahn RA, Der CJ, Bokoch GM. The ras superfamily of GTP-binding proteins: guidelines on nomenclature. FASEB J. 1992;6(8):2512–2513. doi:10.1096/fasebj.6.8.1592203
   PubMed Web of Science ®Google Scholar
• Jang SY, Jang SW, Ko J. Regulation of ADP-ribosylation factor 4 expression by small leucine zipper protein and involvement in breast cancer cell migration. Cancer Lett. 2012;314(2):185–197. doi:10.1016/j.canlet.2011.09.028
   PubMed Web of Science ®Google Scholar
• Mollinedo F. Neutrophil degranulation, plasticity, and cancer metastasis. Trends Immunol. 2019;40(3):228–242. doi:10.1016/j.it.2019.01.006
   PubMed Web of Science ®Google Scholar
• Li Y, Seto E. HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb Perspect Med. 2016;6(10):a026831. doi:10.1101/cshperspect.a026831
   PubMed Web of Science ®Google Scholar
• Vinay DS, Ryan EP, Pawelec G, et al. Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin Cancer Biol. 2015;35:S185–s198. doi:10.1016/j.semcancer.2015.03.004
   PubMed Web of Science ®Google Scholar
• Anichini A, Perotti VE, Sgambelluri F, Mortarini R. Immune escape mechanisms in non small cell lung cancer. Cancers. 2020;12(12):3605. doi:10.3390/cancers12123605
   PubMed Web of Science ®Google Scholar
• Stankovic B, Bjørhovde HAK, Skarshaug R, et al. Immune cell composition in human non-small cell lung cancer. Front Immunol. 2018;9:3101. doi:10.3389/fimmu.2018.03101
   PubMed Web of Science ®Google Scholar
• Ng KW, Marshall EA, Enfield KS, et al. Somatic mutation-associated T follicular helper cell elevation in lung adenocarcinoma. Oncoimmunology. 2018;7(12):e1504728. doi:10.1080/2162402X.2018.1504728
   PubMed Web of Science ®Google Scholar
• Qiu L, Yu Q, Zhou Y, et al. Functionally impaired follicular helper T cells induce regulatory B cells and CD14(+) human leukocyte antigen-DR(-) cell differentiation in non-small cell lung cancer. Cancer Sci. 2018;109(12):3751–3761. doi:10.1111/cas.13836
   PubMed Web of Science ®Google Scholar
• Guo F, Yuan D, Zhang J, et al. Silencing of ARL14 gene induces lung adenocarcinoma cells to a dormant state. Front Cell Dev Biol. 2019;7:238. doi:10.3389/fcell.2019.00238
   PubMed Web of Science ®Google Scholar